| Year |
Citation |
Score |
| 2015 |
Goodsmith N, Guo XV, Vandal OH, Vaubourgeix J, Wang R, Botella H, Song S, Bhatt K, Liba A, Salgame P, Schnappinger D, Ehrt S. Disruption of an M. tuberculosis membrane protein causes a magnesium-dependent cell division defect and failure to persist in mice. Plos Pathogens. 11: e1004645. PMID 25658098 DOI: 10.1371/Journal.Ppat.1004645 |
0.509 |
|
| 2013 |
Hawn TR, Matheson AI, Maley SN, Vandal O. Host-Directed therapeutics for tuberculosis: Can we harness the host? Microbiology and Molecular Biology Reviews. 77: 608-627. PMID 24296574 DOI: 10.1128/MMBR.00032-13 |
0.447 |
|
| 2013 |
Small JL, O'Donoghue AJ, Boritsch EC, Tsodikov OV, Knudsen GM, Vandal O, Craik CS, Ehrt S. Substrate specificity of MarP, a periplasmic protease required for resistance to acid and oxidative stress in Mycobacterium tuberculosis. The Journal of Biological Chemistry. 288: 12489-99. PMID 23504313 DOI: 10.1074/Jbc.M113.456541 |
0.389 |
|
| 2012 |
Robertson BD, Altmann D, Barry C, Bishai B, Cole S, Dick T, Duncan K, Dye C, Ehrt S, Esmail H, Flynn J, Hafner R, Handley G, Hanekom W, van Helden P, ... ... Vandal O, et al. Detection and treatment of subclinical tuberculosis. Tuberculosis (Edinburgh, Scotland). 92: 447-52. PMID 22819716 DOI: 10.1016/J.Tube.2012.06.004 |
0.321 |
|
| 2010 |
Biswas T, Small J, Vandal O, Odaira T, Deng H, Ehrt S, Tsodikov OV. Structural insight into serine protease Rv3671c that Protects M. tuberculosis from oxidative and acidic stress. Structure (London, England : 1993). 18: 1353-63. PMID 20947023 DOI: 10.1016/J.Str.2010.06.017 |
0.425 |
|
| 2009 |
Vandal OH, Nathan CF, Ehrt S. Acid resistance in Mycobacterium tuberculosis. Journal of Bacteriology. 191: 4714-21. PMID 19465648 DOI: 10.1128/Jb.00305-09 |
0.653 |
|
| 2009 |
Vandal OH, Roberts JA, Odaira T, Schnappinger D, Nathan CF, Ehrt S. Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment. Journal of Bacteriology. 191: 625-31. PMID 19011036 DOI: 10.1128/Jb.00932-08 |
0.621 |
|
| 2008 |
Nathan C, Gold B, Lin G, Stegman M, de Carvalho LP, Vandal O, Venugopal A, Bryk R. A philosophy of anti-infectives as a guide in the search for new drugs for tuberculosis. Tuberculosis (Edinburgh, Scotland). 88: S25-33. PMID 18762150 DOI: 10.1016/S1472-9792(08)70034-9 |
0.593 |
|
| 2008 |
Vandal OH, Pierini LM, Schnappinger D, Nathan CF, Ehrt S. A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis. Nature Medicine. 14: 849-54. PMID 18641659 DOI: 10.1038/Nm.1795 |
0.586 |
|
| 2008 |
Bryk R, Gold B, Venugopal A, Singh J, Samy R, Pupek K, Cao H, Popescu C, Gurney M, Hotha S, Cherian J, Rhee K, Ly L, Converse PJ, Ehrt S, ... Vandal O, et al. Selective killing of nonreplicating mycobacteria. Cell Host & Microbe. 3: 137-45. PMID 18329613 DOI: 10.1016/J.Chom.2008.02.003 |
0.597 |
|
| 2006 |
Vandal OH, Gelb MH, Ehrt S, Nathan CF. Cytosolic phospholipase A2 enzymes are not required by mouse bone marrow-derived macrophages for the control of Mycobacterium tuberculosis in vitro. Infection and Immunity. 74: 1751-6. PMID 16495548 DOI: 10.1128/Iai.74.3.1751-1756.2006 |
0.608 |
|
| Show low-probability matches. |